Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy.

Summary
Title
Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy.
Authors
  • Biancini GB
  • Vanzin CS
  • Rodrigues DB
  • Deon M
  • Ribas GS
  • Barschak AG
  • Manfredini V
  • Netto CB
  • Jardim LB
  • Giugliani R
  • Vargas CR
Source
Biochim Biophys Acta
Publication Date
2012 Feb
PubMed ID
22085605

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.4.0

Last updated: December 8, 2025